Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2025-12-24 @ 2:31 PM
NCT ID:
NCT05304559
Eligibility Criteria:
Inclusion Criteria:
Clinical diagnosis of hip fracture
Aged 65 or above
ASA Ⅰ-Ⅲ
No mental and nervous system diseases
No pathological fractures, such as bone tumor, bone tuberculosis, osteomyelitis, etc
No puncture site infection
No hospital stay for more than 48 hours after operation
Exclusion Criteria:
Patients with severe cardiac, hepatic and renal dysfunction before operation
Long-term use of analgesics, sedatives and alcoholism
Patients with respiratory tract management difficulties (modified Ma's score is IV)
Previous neuropsychiatric diseases such as severe cerebrovascular, Alzheimer's disease, epilepsy and Parkinson's disease
Previous history of intracranial surgery or craniocerebral injury
Severe vision, hearing, language impairment or other reasons unable to communicate
Allergic or contraindicated to ropivacaine or non-steroidal anti-inflammatory drugs (NSAID)
Emergency surgery or trauma patients.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
65 Years
Maximum Age:
85 Years
Study:
NCT05304559
Study Brief:
Protocol Section:
NCT05304559